349 related articles for article (PubMed ID: 26897538)
1. Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria.
Ma L; Wang Y; Wang M; Tian Y; Kang W; Liu H; Wang H; Dou J; Zhou C
Biomaterials; 2016 May; 87():32-45. PubMed ID: 26897538
[TBL] [Abstract][Full Text] [Related]
2. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
[TBL] [Abstract][Full Text] [Related]
3. Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids.
Kang W; Liu H; Ma L; Wang M; Wei S; Sun P; Jiang M; Guo M; Zhou C; Dou J
Eur J Pharm Sci; 2017 Jul; 105():169-177. PubMed ID: 28522372
[TBL] [Abstract][Full Text] [Related]
4. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria.
Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R
Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activities of peptide Cbf-K
Jiang M; Ma L; Huang Y; Wu H; Dou J; Zhou C
Microb Pathog; 2020 Jan; 138():103847. PubMed ID: 31704464
[TBL] [Abstract][Full Text] [Related]
6. An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo.
Jiang M; Yang X; Wu H; Huang Y; Dou J; Zhou C; Ma L
Biochem Pharmacol; 2020 Feb; 172():113746. PubMed ID: 31812678
[TBL] [Abstract][Full Text] [Related]
7. Cbf-14, a cationic peptide derived from cathelin-domain, exhibits anti-inflammation activity via inhibiting PI3K- Akt /ROS/ NF-κB signaling pathway.
Xie X; He L; Wang Y; Ye X; Ma L
Peptides; 2023 Aug; 166():171040. PubMed ID: 37295650
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
Lee JK; Seo CH; Luchian T; Park Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
[TBL] [Abstract][Full Text] [Related]
9. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
Datta A; Kundu P; Bhunia A
J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
[TBL] [Abstract][Full Text] [Related]
10. High Selective Performance of Designed Antibacterial and Anticancer Peptide Amphiphiles.
Chen C; Chen Y; Yang C; Zeng P; Xu H; Pan F; Lu JR
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17346-55. PubMed ID: 26204061
[TBL] [Abstract][Full Text] [Related]
11. Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity.
Kim YM; Kim NH; Lee JW; Jang JS; Park YH; Park SC; Jang MK
Biochem Biophys Res Commun; 2015 Jul; 463(3):322-8. PubMed ID: 26028561
[TBL] [Abstract][Full Text] [Related]
12. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of Polybia paulista.
Wang K; Yan J; Dang W; Liu X; Chen R; Zhang J; Zhang B; Zhang W; Kai M; Yan W; Yang Z; Xie J; Wang R
Peptides; 2013 Jan; 39():80-8. PubMed ID: 23159560
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.
Faccone D; Veliz O; Corso A; Noguera M; Martínez M; Payes C; Semorile L; Maffía PC
Eur J Med Chem; 2014 Jan; 71():31-5. PubMed ID: 24269514
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
[TBL] [Abstract][Full Text] [Related]
15. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
[TBL] [Abstract][Full Text] [Related]
16. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
Eley A; Ibrahim M; Kurdi SE; Conlon JM
Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
[TBL] [Abstract][Full Text] [Related]
17. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
[TBL] [Abstract][Full Text] [Related]
18. The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.
Aghazadeh H; Memariani H; Ranjbar R; Pooshang Bagheri K
Chem Biol Drug Des; 2019 Jan; 93(1):75-83. PubMed ID: 30120878
[TBL] [Abstract][Full Text] [Related]
19. Membrane interaction and antibacterial properties of chensinin-1, an antimicrobial peptide with atypical structural features from the skin of Rana chensinensis.
Shang D; Sun Y; Wang C; Wei S; Ma L; Sun L
Appl Microbiol Biotechnol; 2012 Dec; 96(6):1551-60. PubMed ID: 22581068
[TBL] [Abstract][Full Text] [Related]
20. Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.
Zhang Q; Xu Y; Wang Q; Hang B; Sun Y; Wei X; Hu J
Antimicrob Agents Chemother; 2015 May; 59(5):2835-41. PubMed ID: 25753638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
